William Blair analyst Matt Larew initiates coverage on MaxCyte (NASDAQ:MXCT) with a Outperform rating.
William Blair Initiates Coverage On MaxCyte with Outperform Rating
William Blair analyst Matt Larew initiates coverage on MaxCyte (NASDAQ:MXCT) with a Outperform rating.